USPTO serial 87892530
ENTYVIOCONNECT BRIDGE
Reviewed by CopyMark Law Group
Reg. 5846457Status 710
- Filing date
- Status date
- Registration date
- Aug 27, 2019
- Examiner
- PINO, BRIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ENTYVIOCONNECT BRIDGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Millennium Pharmaceuticals, Inc.
Cambridge, DE, US
Millennium Pharmaceuticals, Inc.
Cambridge, DE, US
Millennium Pharmaceuticals, Inc.
Cambridge, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. Troutman Sanders LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Providing a health care patient access program to provide drugs free of charge on a continuing basis to eligible patients experiencing a sudden loss or gap in their commercial coverage, namely, financial administration of medication reimbursement programs and services | SECTION 8 - CANCELLED | Jul 23, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks owned by Millennium Pharmaceuticals, Inc.
- Other trademarks in Class 036
- Similar marks named ENTYVIOCONNECT BRIDGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 13, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 27, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 23, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 29, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 27, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 25, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 24, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 18, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 18, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 26, 2019 | IUAF | USE AMENDMENT FILED | — |
| Jun 26, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 5, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 8, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 8, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 19, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 30, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 29, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 22, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 29, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 29, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 29, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 22, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |